The Search for Simplicity, Scalability and Timely Insights in Regulatory Affairs
Rising Expectations from Regulatory Affairs Executives As we all know ...
ArisGlobal Viewpoint: How Digitization Changes the Role of Regulatory Affairs
This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.
ArisGlobal Expert Shares How Regulatory Affairs Needs to Adapt to Transformation Change
The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound effect on regulatory affairs.
